Pharmaceutical product overview
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Alzheimer's disease |  |
391 |
32% |
| Epilepsy |  |
245 |
20% |
| Parkinson's disease |   |
245 |
23% |
| Attention deficit disorder |   |
220 |
14% |
| Epilepsy |  |
173 |
-56% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Hypertension |   |
2878 |
20% |
| Cholesterol reduction |  |
337 |
-1% |
| Hypertension |  |
195 |
-67% |
| Hypertension |  |
173 |
541% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Asthma |  |
209 |
16% |
| Cystic Fibrosis | Tobramycin |
145 |
8% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Transplantation |  |
503 |
10% |
| Transplantation |  |
141 |
66% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Chronic myeloid leukemia |  |
1830 |
29% |
| Cancer complications |  |
677 |
6% |
| Breast cancer |  |
561 |
28% |
| Acromegaly |  |
558 |
14% |
| Iron chelator |  |
238 |
52% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD | Inflammation / pain |  |
418 |
17% |
| Indication | Product | Half Year 2008 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Age-related macular degeneration |  |
437 |
333 |
Quarterly results
View and download the latest quarterly reports from Novartis.
Corporate publications
